id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-P-1562-0004,FDA,FDA-2025-P-1562,"Determination That DEXCHLORPHENIRAMINE MALEATE (Dexchlorpheniramine Maleate, Oral Syrup, 2 Milligrams/5 Milliliters) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T19:43:25Z,2025-23419,0,0,09000064b90f5231
FDA-2025-P-1562-0005,FDA,FDA-2025-P-1562,Response Letter,Other,Letter(s),2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T21:21:09Z,,0,0,09000064b90f5eb9
FDA-2025-P-1562-0003,FDA,FDA-2025-P-1562,Interim Response,Other,Letter(s),2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,,2025-12-01T23:23:05Z,,0,0,09000064b90a43b1
FDA-2025-P-1562-0002,FDA,FDA-2025-P-1562,"Acknowledgement Letter from FDA DMB to Pharmobedient Consulting, LLC",Other,Acknowledgement Letter/Receipt,2025-06-04T04:00:00Z,2025,6,2025-06-04T04:00:00Z,,2025-06-05T01:58:22Z,,0,0,09000064b8dd9154
FDA-2025-P-1562-0001,FDA,FDA-2025-P-1562,"Citizen Petition from Pharmobedient Consulting, LLC",Other,Citizen Petition,2025-06-04T04:00:00Z,2025,6,2025-06-04T04:00:00Z,,2025-12-19T20:51:24Z,,0,0,09000064b8dd9152